462 related articles for article (PubMed ID: 8035989)
1. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
3. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
Jabs DA
Infect Agents Dis; 1995 Sep; 4(3):131-42. PubMed ID: 8548191
[TBL] [Abstract][Full Text] [Related]
4. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
Arch Intern Med; 1995 Jan; 155(1):65-74. PubMed ID: 7802522
[TBL] [Abstract][Full Text] [Related]
6. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
Jacobson MA; Wulfsohn M; Feinberg JE; Davis R; Power M; Owens S; Causey D; Heath-Chiozzi ME; Murphy RL; Cheung TW
AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
[TBL] [Abstract][Full Text] [Related]
7. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cytomegalovirus retinitis. Clinical evaluation vs centralized grading of fundus photographs. Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jul; 114(7):791-805. PubMed ID: 8660161
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA
Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309
[TBL] [Abstract][Full Text] [Related]
10. Studies of ocular complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design, and methods. AIDS Clinical Trials Group (ACTG).
Control Clin Trials; 1992 Feb; 13(1):22-39. PubMed ID: 1315661
[TBL] [Abstract][Full Text] [Related]
11. Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial.
Jabs DA
Antiviral Res; 1996 Jan; 29(1):69-71. PubMed ID: 8721550
[TBL] [Abstract][Full Text] [Related]
12. Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Roarty JD; Fisher EJ; Nussbaum JJ
Ophthalmology; 1993 Nov; 100(11):1685-8. PubMed ID: 8233395
[TBL] [Abstract][Full Text] [Related]
13. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
14. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
Nagata Y; Fujino Y; Ono A; Mochizuki M; Mouri H; Oka S; Kimura S; Shimada K
Nippon Ganka Gakkai Zasshi; 1994 Jul; 98(7):710-5. PubMed ID: 8067306
[TBL] [Abstract][Full Text] [Related]
15. Survival differences associated with treatment of cytomegalovirus retinitis in Maryland patients with AIDS, 1987-1994.
Wutoh AK; Hidalgo J; Rhee W; Bareta J; Steidl S
Am J Health Syst Pharm; 1999 Jul; 56(13):1314-8. PubMed ID: 10683128
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.
Martin DF; Parks DJ; Mellow SD; Ferris FL; Walton RC; Remaley NA; Chew EY; Ashton P; Davis MD; Nussenblatt RB
Arch Ophthalmol; 1994 Dec; 112(12):1531-9. PubMed ID: 7993207
[TBL] [Abstract][Full Text] [Related]
17. Ocular manifestations of HIV infection.
Jabs DA
Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcome in patients with AIDS and CMV retinitis treated with foscarnet or ganciclovir. Studies of Ocular Complications of AIDS (SOCA) in collaboration with the AIDS Clinical Trial Group.
J Infect Dis; 1997 Jul; 176(1):50-8. PubMed ID: 9207349
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
Mansor AM; Li HK
Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
[TBL] [Abstract][Full Text] [Related]
20. Current management of cytomegalovirus disease in patients with AIDS.
Jacobson MA
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):917-23. PubMed ID: 7811543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
